Miriam L. Sharpe

Miriam L. Sharpe

Auto-generated profile, based on publicly available information

Miriam L. Sharpe

Department of Biochemistry, University of Otago, Dunedin, New Zealand

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2009 in Nature
Verified
Journal Article
Closed access
PDF file
RMRaphael Margueron
Raphael Margueron
NJNeil Justin
Neil Justin
KOKatsuhito Ohno
Katsuhito Ohno
MSMiriam L. Sharpe
Miriam L. Sharpe
JSJinsook Son
Jinsook Son
SGSteven J. Gamblin
Steven J. Gamblin

21 October 2015 in BMC Genomics
Verified
Journal Article
Open access
PDF file
MSMiriam L. Sharpe
Miriam L. Sharpe
PDPeter Dearden
Peter Dearden
GGGregory Gimenez
Gregory Gimenez
KKKurt Krause
Kurt Krause
The New Zealand glowworm is the larva of a carnivorous fungus gnat that produces bioluminescence to attract prey. The bioluminescent system of the glowworm is evolutionarily distinct from other well-characterised systems, especially that of the fireflies, and the molecules involved have not yet been identified. We have used high throughput sequencing technology to produce a transcriptome for the glowworm and identify transcripts encoding proteins that are likely to be involved in glowworm bioluminescence. Here we report the sequencing and annotation of the first transcriptome of the glowworm, and a differential analysis of expression from the glowworm light organ compared with non-light organ tissue. The analysis identified six transcripts encoding proteins that are potentially involved in glowworm bioluminescence. Three of these proteins are members of the ANL superfamily of adenylating enzymes, with similar amino acid sequences to that of the luciferase enzyme found in fireflies (31 to 37 % identical), and are candidate luciferases for the glowworm bioluminescent system. The remaining three transcripts encode putative aminoacylase, phosphatidylethanolamine-binding and glutathione S-transferase proteins. This research provides a basis for further biochemical studies into how the glowworm produces light, and a source of genetic information to aid future ecological and evolutionary studies of the glowworm.

10 September 2010 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
WPWayne M. Patrick
Wayne M. Patrick
YNYoshio Nakatani
Yoshio Nakatani
SCSusan M. Cutfield
Susan M. Cutfield
MSMiriam L. Sharpe
Miriam L. Sharpe
RRRochelle J. Ramsay
Rochelle J. Ramsay
JCJohn F. Cutfield
John F. Cutfield
Candida albicans exo‐β‐1,3‐glucanase (Exg; EC 3.2.1.58) is implicated in cell wall β‐d‐glucan remodelling through its glucosyl hydrolase and/or transglucosylase activities. A pair of antiparallel phenylalanyl residues (F144 and F258) flank the entrance to the active site pocket. Various Exg mutants were studied using steady‐state kinetics and crystallography aiming to understand the roles played by these residues in positioning the β‐1,3‐d‐glucan substrate. Mutations at the Phe‐Phe entranceway demonstrated the requirement for double‐sided CH/π interactions at the +1 subsite, and the necessity for phenylalanine rather than tyrosine or tryptophan. The Tyr‐Tyr double mutations introduced ordered water molecules into the entranceway. A third Phe residue (F229) nearby was evaluated as a possible +2 subsite. The inactive double mutant E292S/F229A complexed with laminaritriose has provided the first picture of substrate binding to Exg and demonstrated how the Phe‐Phe arrangement acts as a clamp at the +1 subsite. The terminal sugar at the −1 site showed displacement from the position of a monosaccharide analogue with interchange of water molecules and sugar hydroxyls. An unexpected additional glucose binding site, well removed from the active site, was revealed. This site may enable Exg to associate with the branched glucan structure of the C. albicans cell wall.

19 February 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
OWOliver Claire Watkins
Oliver Claire Watkins
MSMiriam L. Sharpe
Miriam L. Sharpe
NPNigel B. Perry
Nigel B. Perry
KKKurt Krause
Kurt Krause
The New Zealand glowworm, Arachnocampa luminosa, is well-known for displays of blue-green bioluminescence, but details of its bioluminescent chemistry have been elusive. The glowworm is evolutionarily distant from other bioluminescent creatures studied in detail, including the firefly. We have isolated and characterised the molecular components of the glowworm luciferase-luciferin system using chromatography, mass spectrometry and 1H NMR spectroscopy. The purified luciferase enzyme is in the same protein family as firefly luciferase (31% sequence identity). However, the luciferin substrate of this enzyme is produced from xanthurenic acid and tyrosine, and is entirely different to that of the firefly and known luciferins of other glowing creatures. A candidate luciferin structure is proposed, which needs to be confirmed by chemical synthesis and bioluminescence assays. These findings show that luciferases can evolve independently from the same family of enzymes to produce light using structurally different luciferins.

25 May 2011 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
HIHookang Im
Hookang Im
MSMiriam L Sharpe
Miriam L Sharpe
USUlrich Strych
Ulrich Strych
MDMilya Davlieva
Milya Davlieva
KKKurt Krause
Kurt Krause
Background: Streptococcus pneumoniae is a globally important pathogen. The Gram-positive diplococcus is a leading cause of pneumonia, otitis media, bacteremia, and meningitis, and antibiotic resistant strains have become increasingly common over recent years.Alanine racemase is a ubiquitous enzyme among bacteria and provides the essential cell wall precursor, D-alanine. Since it is absent in humans, this enzyme is an attractive target for the development of drugs against S. pneumoniae and other bacterial pathogens. Results: Here we report the crystal structure of alanine racemase from S. pneumoniae (AlrSP). Crystals diffracted to a resolution of 2.0 Å and belong to the space group P3121 with the unit cell parameters a = b = 119.97 Å, c = 118.10 Å, α = β = 90° and γ = 120°. Structural comparisons show that AlrSP shares both an overall fold and key active site residues with other bacterial alanine racemases. The active site cavity is similar to other Gram positive alanine racemases, featuring a restricted but conserved entryway. Conclusions: We have solved the structure of AlrSP, an essential step towards the development of an accurate pharmacophore model of the enzyme, and an important contribution towards our on-going alanine racemase structure-based drug design project. We have identified three regions on the enzyme that could be targeted for inhibitor design, the active site, the dimer interface, and the active site entryway.